Cargando…

Long-Term Dynamic Humoral Response to SARS-CoV-2 mRNA Vaccines in Patients on Peritoneal Dialysis

Introduction. Patients on peritoneal dialysis (PD) present an impaired humoral response against SARS-CoV-2, at least after the initial vaccination and booster dose. Until now, the effect of a fourth dose has not been established. The aim of the present study is to evaluate the long-term dynamics of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quiroga, Borja, Soler, María José, Ortiz, Alberto, Gansevoort, Ron T., Leyva, Alba, Rojas, José, de Sequera, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609237/ https://www.ncbi.nlm.nih.gov/pubmed/36298603 http://dx.doi.org/10.3390/vaccines10101738

Ejemplares similares

Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
por: Quiroga, Borja, et al.
Publicado: (2022)

Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
por: Quiroga, Borja, et al.
Publicado: (2023)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council
por: de Sequera, Patricia, et al.
Publicado: (2022)

Suboptimal personal protective equipment and SARS-CoV-2 infection in Nephrologists: a Spanish national survey
por: Quiroga, Borja, et al.
Publicado: (2021)

SARS-CoV-2 Infection Evolution Among Nephrologists During the Pandemic: Clinical Features and Impact of Vaccination
por: Quiroga, Borja, et al.
Publicado: (2022)

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines()
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Posicionamiento de la Sociedad Española de Nefrología ante la vacunación frente al SARS-CoV-2
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

Actualización de las recomendaciones de medidas de prevención y aislamiento frente al SARS-CoV-2 en las unidades de diálisis: un posicionamiento de la Sociedad Española de Nefrología
por: de Sequera, Patricia, et al.
Publicado: (2022)

Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
por: Quiroga, Borja, et al.
Publicado: (2022)

Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant()
por: de Sequera Ortiz, Patricia, et al.
Publicado: (2020)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis
por: Vischini, Gisella, et al.
Publicado: (2020)

Correction to: From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
por: Quiroga, Borja, et al.
Publicado: (2022)

From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
por: Quiroga, Borja, et al.
Publicado: (2022)

POS-685 SARS-COV2 INFECTION IN PATIENTS ON PERITONEAL DIALYSIS
por: Bettaieb, A., et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing dialysis
por: Lee, Yoo Jin, et al.
Publicado: (2022)

Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis
por: Li, Tingting, et al.
Publicado: (2022)

Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times
por: Bachelet, Thomas, et al.
Publicado: (2021)

Under-Recognized Pathogens in Peritoneal Dialysis Associated-Peritonitis: The Importance of Early Detection
por: Domingues, Patrícia, et al.
Publicado: (2023)

Letter regarding “SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis”
por: Candellier, Alexandre, et al.
Publicado: (2020)

Strategies to Protect Dialysis Patients against Bisphenol A
por: Quiroga, Borja
Publicado: (2021)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort
por: Beilhack, Georg, et al.
Publicado: (2021)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2023)

Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2
por: Speer, Claudius, et al.
Publicado: (2021)

Pregnancy in a woman undergoing peritoneal dialysis: Management and dialysis options
por: Veríssimo, Rita, et al.
Publicado: (2022)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Pantoea in Peritoneal Dialysis: A Rare Cause of Peritonitis
por: Mateus, Catarina, et al.
Publicado: (2022)

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2022)

Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients
por: Laham, Gustavo, et al.
Publicado: (2022)

Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients
por: Berar-Yanay, Noa, et al.
Publicado: (2021)

Can SARS-CoV-2 be found in the effluent from peritoneal dialysis patients?
por: Candellier, Alexandre, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
por: Hernández-Porto, Miriam, et al.
Publicado: (2022)

Effect of Lymphocyte Phenotypic Alterations on the Humoral Response to Vaccination Against SARS-COV-2 in Dialysis Patients
por: Lioulios, Georgios, et al.
Publicado: (2023)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eadgegmkoublq8et214ie1fsnr